High insulin levels raise risk of breast cancer in postmenopausal women

January 12, 2009

Higher-than-normal levels of insulin place postmenopausal women at increased risk of breast cancer, researchers at Albert Einstein College of Medicine of Yeshiva University report. Their findings, published in the January 7 issue of the Journal of the National Cancer Institute, suggest that interventions that target insulin and its signaling pathways may decrease breast cancer risk in these women.

Breast cancer is the most common cancer among women in the United States. Last year, approximately 182,000 women were diagnosed with breast cancer and more than 40,000 died from the disease. The majority of breast cancers arise in women past the age of menopause.

Obesity is a well-established risk factor for postmenopausal breast cancer, but just how obesity and breast cancer are connected is unclear. Many researchers have assumed that the link is estrogen-a hormone that is known to increase breast-cancer risk and is found at higher-than-average levels in obese women. But obese women also have other hormonal imbalances that may play a role in triggering breast cancer. One such imbalance is elevated levels of insulin, which stimulates the growth of breast cells in tissue culture. The Einstein study is the first to prospectively identify insulin's role in breast cancer while controlling for estrogen levels.

The multi-year Women's Health Initiative (WHI)-the largest study of postmenopausal women ever funded by the National Institutes of Health-followed health outcomes in more than 93,000 postmenopausal women. At enrollment, each participant donated blood samples that were stored for later analysis.

In 2004, the Einstein researchers selected a subset of more than 1,600 of these participants: 835 who had developed breast cancer during the study, and a random sample of 816 women representative of the WHI as a whole. Using the blood samples and other measurements taken when the women enrolled, the researchers assessed their fasting insulin level, naturally occurring levels of estradiol (a form of estrogen), and body mass index, or BMI (a measure of obesity). After dividing the women into four groups based on their fasting insulin levels and controlling for estrogen levels, the researchers found that women with the highest insulin levels were nearly 50 percent more likely to have developed breast cancer compared with women who had the lowest insulin levels.

Most of this effect was observed in the large subset of women from the WHI study who did not use hormone-replacement therapy. HRT has a strong effect on insulin and other hormonal factors, so eliminating this variable gives a clearer picture of insulin's effect on breast cancer. "Among these women, the influence of insulin on breast cancer risk was quite high," says lead author Marc Gunter, Ph.D., assistant professor of epidemiology & population health at Einstein. "Women with the highest insulin levels in their blood were more than two times more likely to develop breast cancer than women with the lowest insulin levels." Moreover, "when we controlled for insulin, the association between obesity and breast cancer became much weaker," adds Dr. Gunter. "This means that a large component of that obesity-cancer relationship may be mediated by insulin levels."

The findings have important implications for prevention, and possibly treatment, of postmenopausal breast cancer, according to Howard Strickler, M.D., M.P.H, who was senior author of the paper and a professor of epidemiology & population health at Einstein. "Research now needs to focus on ways to reduce insulin's effects on cell growth and replication in the breast while preserving its positive metabolic effects.

There are several possibilities and working with our laboratory collaborators we hope to make fast progress," said Dr. Strickler.

"It is also possible that screening non-diabetic postmenopausal women for high insulin levels could prove useful in identifying individuals at high risk for breast cancer," says Dr. Strickler.

The current study is part of a broader research program at Einstein. Researchers are focusing on how the effects of insulin and insulin-like growth factors on cell replication and survival influence a variety of conditions. "Every cell in the body carries insulin receptors and most carry IGF-1 receptors, so it makes sense that this biologic pathway could play a major role in health and disease across a broad range of conditions and we have to do much more to understand these relationships,"notes Dr. Strickler. So far, studies by Dr. Strickler and his colleagues have shown that insulin and/or IGFs also play a role in endometrial and colorectal cancer, as well as the progression of certain viral diseases, including HIV, hepatitis C virus in the liver and human papillomavirus (the cause of cervical cancer).

Albert Einstein College of Medicine

---

---

	Primary Care Use of FRAX®: Absolute Fracture Risk Assessment in Postmenopausal Women and Older Men (Postgraduate Medicine) by JTE Multimedia Osteoporosis-related fractures (low-trauma or fragility fractures) cause substantial disability, health care costs, and mortality among postmenopausal women and older men. Epidemiologic studies indicate that at least half the population burden of osteoporosis-related fractures affects persons with osteopenia (low bone density), who comprise a larger segment of the population than those with osteoporosis. The public health burden of fractures will fail to decrease unless the subset of patients with low bone density who are at increased risk for fracture are identified and treated. Risk stratification for medically appropriate and cost-effective treatment is facilitated by the World Health Organization (WHO) FRAX® algorithm, which uses clinical risk factors, bone mineral density, and...
	Routine Bone Scans Rare in Postmenopausal Women.(Brief Article): An article from: Family Practice News by Sherry Boschert (Author) This digital document is an article from Family Practice News, published by International Medical News Group on September 1, 2000. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Routine Bone Scans Rare in Postmenopausal Women.(Brief Article) Author: Sherry Boschert Publication: Family Practice News (Magazine/Journal) Date: September 1, 2000 Publisher: International Medical News Group Volume: 30 Issue: 17 Page: 34 Article Type: Brief Article Distributed by Thomson...
	Soy nuts may cut BP in postmenopausal women. (Controlled Pilot Study).(blood pressure): An article from: Family Practice News by Mitchel L. Zoler (Author) This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2003. The length of the article is 781 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Soy nuts may cut BP in postmenopausal women. (Controlled Pilot Study).(blood pressure) Author: Mitchel L. Zoler Publication: Family Practice News (Magazine/Journal) Date: March 1, 2003 Publisher: International Medical News Group Volume: 33 Issue: 5 Page: 42(1) Distributed by Thomson...
	HT may benefit postmenopausal cognition, memory: three new studies contradict past results.(News)(Hormone therapy): An article from: Internal Medicine News by Michele G. Sullivan (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on September 1, 2008. The length of the article is 1199 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: HT may benefit postmenopausal cognition, memory: three new studies contradict past results.(News)(Hormone therapy) Author: Michele G. Sullivan Publication: Internal Medicine News (Magazine/Journal) Date: September 1, 2008 Publisher: International Medical News Group Volume: 41 Issue: 17 Page: 1(3) Distributed by Gale, a part of Cengage...
	Denosumab for the Management of Postmenopausal Osteoporosis (Postgraduate Medicine) by JTE Multimedia Postmenopausal osteoporosis is a major concern to public health. Fractures are the major clinical consequence of osteoporosis and are associated with substantial morbidity, mortality, and health care costs. Despite the availability of screening and treatment guidelines, osteoporosis diagnosis and treatment remain low. Health care providers may consult guidelines in the clinical management of their patients with osteoporosis, including those from the National Osteoporosis Foundation, and the new fracture risk assessment tool from the World Health Organization. Bisphosphonates are the most commonly used treatment for postmenopausal osteoporosis. Although these agents are effective in preventing fractures and bone loss, the benefits of treatment may be limited by suboptimal adherence and...
	Once-a-Month Risedronate in Postmenopausal Osteoporosis (Postgradaute Medicine) by JTE Multimedia Abstract: Original Article Delmas PD, McClung MR, Zanchetta JR, et al. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. Bone. 2008;42(1):36–42 PRACTICE PEARL This study demonstrates the efficacy, safety, and convenience of once-a-month risedronate versus a once-daily dose. Original Publication Date: July 2009
	Hypertension in Postmenopausal Women by Messerli (Author) This practical reference reviews the epidemiology of hypertensive cardiovascular disease in menopause and its relationship to coronary heart disease-examining concurrent risk factors such as lipid abnormalities, obesity, physical activity, and smoking and discussing the use of estrogen replacement therapy to reduce cardiovascular mortality.
	ATTITUDES TOWARD POST-MENOPAUSAL WOMEN IN THE HIGH AND LATE MIDDLE AGES, 1100-1400 by Jessica E Godfrey (Author) Very little has been written on the subject of old age in pre-industrial Europe and even less on old women. The topic of post-menopausal women in the Middle Ages has not received much attention in historical scholarship.
	Hormones and Breast Cancer in Post-Menopausal Women (Breast Disease, Vol. 24) by S.Z. Haslam (Author), S.Z. Haslam (Editor), J.R. Osuch (Editor) In 2006, invasive breast cancer is estimated to be diagnosed in 212,920 women and 1,720 men in the US, thus affecting women at a rate almost 200 times that of men. The description of breast tumors as a primary phenomenon of the female gender is documented in medical writings dating as far back as those contained in the ancient Egyptian papyrus acquired by Edwin Smith, which document cases of breast tumors as early as 1600 B.C. It would take nearly 2,000 years to recognize that the predominance of breast disease in women had a relationship to the chemical differences that exist between women and men. Of the 212,920 women to be diagnosed with breast cancer in 2006, 163,948 will be postmenopausal. The editors hope that the articles in this publication will highlight the challenges of...
	Postmenopausal: Webster's Timeline History, 1944 - 2004 by Icon Group International (Author) Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Postmenopausal," including when used in literature (e.g. all authors that might have Postmenopausal in their name). As such, this book represents the largest compilation of timeline events associated with Postmenopausal when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts,...